Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED

(3613)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Beijing Tong Ren Tang Chinese Medicine : Profit, Revenue Drop in 2020; Shares Jump 8%

03/11/2021 | 11:28pm EDT


© MT Newswires 2021
All news about BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED
05/28Beijing Tong Ren Tang Chinese Medicine Company Limited Approves Final Dividen..
CI
04/28BEIJING TONG REN TANG CHINESE MEDICI : Financial Information Announcement of Ton..
PU
04/21BEIJING TONG REN TANG CHINESE MEDICI : Form of Proxy for Annual General Meeting ..
PU
04/21BEIJING TONG REN TANG CHINESE MEDICI : (1) Proposals for General Mandates to Iss..
PU
03/11BEIJING TONG REN TANG CHINESE MEDICI : Profit, Revenue Drop in 2020; Shares Jump..
MT
03/11BEIJING TONG REN TANG CHINESE MEDICI : CEO Retires; Replacement Named
MT
03/11BEIJING TONG REN TANG CHINESE MEDICI : Retirement of executive director, chief e..
PU
03/11BEIJING TONG REN TANG CHINESE MEDICI : Forfeiture of unclaimed dividends
PU
03/11Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Executive Ch..
CI
03/11Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Appointment ..
CI
More news
Financials
Sales 2021 1 452 M 187 M 187 M
Net income 2021 596 M 76,7 M 76,7 M
Net cash 2021 2 146 M 276 M 276 M
P/E ratio 2021 16,8x
Yield 2021 2,14%
Capitalization 10 028 M 1 291 M 1 291 M
EV / Sales 2021 5,43x
EV / Sales 2022 4,55x
Nbr of Employees 754
Free-Float 28,2%
Chart BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED
Duration : Period :
Beijing Tong Ren Tang Chinese Medicine Company Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 11,98 HKD
Average target price 14,23 HKD
Spread / Average Target 18,8%
EPS Revisions
Managers and Directors
Fei Chen Chief Executive Officer & Executive Director
Fung Yi Tsang Chief Financial Officer & Secretary
Yong Ling Ding Chairman
Xia Li Chief Engineer
Man Lin Chief Operating Officer & Executive Director
Sector and Competitors
1st jan.Capi. (M$)
BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED46.99%1 206
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG1.10%207 246